Evidence map›Paper›PMID 41140429›Full record

ArticleJournal of neurological surgery. Part B, Skull base2025

The Impact of Venous Stenting on Symptoms and Quality of Life in Patients with Idiopathic Intracranial Hypertension and Spontaneous Cerebrospinal Fluid Leak.

Shreya Mandloi, Areeba Nisar, Samuel R Shing, Chase Kahn, Peter A Benedict, Alexander Duffy, Kareem E Naamani, David Bray, M Reid Gooch, Elina Toskala and 6 more

Abstract read
In one paragraph

Article in Journal of neurological surgery. Part B, Skull base, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shreya MandloiDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Areeba NisarJefferson Headache Center, Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Samuel R ShingDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.ORCID 0000-0002-0350-7398
Chase KahnDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Peter A BenedictDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Alexander DuffyDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Kareem E NaamaniDepartment of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
David BrayDepartment of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
M Reid GoochDepartment of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Elina ToskalaDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
James EvansDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Christopher FarrellDepartment of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Marc RosenDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Mindy R RabinowitzDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Hsiangkuo YuanJefferson Headache Center, Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
Gurston G NyquistDepartment of Otolaryngology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Elevated intracranial pressure can cause skull base defects and a spontaneous cerebrospinal fluid (CSF) leak. Venous sinus stenting (VSS) has emerged as a promising treatment option for patients with a CSF leak in the setting of idiopathic intracranial hypertension (IIH). There is a lack of literature on symptomatology and quality of life (QOL) after VSS for IIH patients with a CSF leak. This study explores the effects of VSS on symptoms and QOL in IIH patients with a CSF leak. Methods: This is a retrospective study on patients who have IIH complicated by a CSF leak and underwent VSS. A QOL questionnaire was developed from the migraine disability assessment test and the PROMIS-PI was given to patients included in this study. Results: A total of 10 patients were included in this study. Nine patients underwent endoscopic closure of CSF prior to stent placement and one patient was treated with VSS only. There was no evidence of CSF leak recurrence in this population following VSS. Headaches improved in 5/8, tinnitus in 5/6, and visual disturbance in 4/5 patients. Diamox was discontinued in seven out of eight patients after VSS. There was an improvement in headache-specific questions ( Discussion: This preliminary study demonstrates that VSS is effective in alleviating many symptoms in IIH patients with a CSF leak, especially headaches. Diamox may be able to be discontinued in many patients following VSS. No CSF leak recurrence was noted in this patient population.

Indexed as

idiopathic intracranial hypertensionskull basespontaneous cerebrospinal fluid leakvenous sinus stenting

Identifiers

PMID41140429
PMCPMC12552043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.